Pfizer's Kindler Joins BIO Board of Directors
The Biotechnology Industry Organization (BIO) announced the election of Pfizer Chairman and CEO Jeffrey B. Kindler to BIO's Board of Directors. Kindler will replace Pfizer Vice President of Corporate Policy and Strategic Management Fred Telling, who had served on the BIO Board for eleven years and is retiring from Pfizer this year.
Mr. Kindler was appointed CEO and elected to Pfizer's Board of Directors in 2006. He first joined Pfizer in 2002 as Executive Vice President and General Counsel, with responsibility for Pfizer's Legal Division, where he led the company's worldwide legal, compliance, communications, government relations, corporate citizenship, policy development and global security groups. He was named Vice Chairman in 2005, joining the company's four-person Executive Committee and assuming responsibility for Pfizer's Corporate Affairs Division.
Mr. Kindler holds a BA from Tufts University as well as a JD from Harvard, where he was an editor of the Harvard Law Review. He began his legal career as an attorney at the Federal Communications Commission. He later served as law clerk to U.S. Supreme Court Justice William J. Brennan, Jr. before joining the law firm of Williams & Connolly as a partner.
Kindler began his corporate career at General Electric and later served in executive positions with the McDonald's Corporation.
Other news from the department people
